• Ashton Invests
  • Posts
  • Why Healthcare Could Mint More Millionaires Than Tech This Decade

Why Healthcare Could Mint More Millionaires Than Tech This Decade

Healthcare vs. Tech

Most investors are glued to AI, semiconductors, and the Magnificent 7. And it makes sense — these areas have created huge wealth over the past decade.

But when I zoom out and think about the next 10 years, I keep coming back to a different sector: healthcare.

It may not get the same hype, but it has the ingredients for massive wealth creation: size, necessity, inefficiency, and innovation.

A Market Too Big to Ignore

Healthcare isn’t just another sector — it’s nearly 20% of U.S. GDP.

Globally, we’re talking about an industry that’s projected to surpass $10 trillion in spending within just a few years. And unlike cyclical sectors, healthcare demand isn’t optional.

People don’t “cut back” on medical needs because of a weak economy. Populations are aging, life expectancy is rising, and healthcare costs are climbing year after year.

That means demand is locked in — the only question is which companies will capture it.

Where the Opportunity Lies

For all its size, healthcare is still one of the most inefficient industries in the world.

  • Insurance paperwork is still clunky and expensive.

  • Providers rely on outdated tech and legacy systems.

  • Patient experiences are often slow, confusing, and impersonal.

Those inefficiencies leave the door wide open for disruption. And when you mix in new technologies like AI and telehealth, the potential gets even bigger.

The Disruptors Changing the Game

Here are a couple of the companies I think are tackling those inefficiencies head on:

  • $HIMS → Building a modern, direct-to-consumer healthcare brand. They’re expanding from telehealth into mental health, weight loss, and beyond. Think of them as creating the “Amazon of healthcare.”

  • $OSCR → A tech-first insurance company that uses data to lower costs and improve member experiences. Insurance is a massive, sticky market — and Oscar is just scratching the surface.

Both of these companies are relatively small compared to the giants of healthcare, but the markets they’re addressing are enormous.

The Power of Boring Compounders

Not all winners will be disruptors. Some will be the “boring” names that quietly deliver year after year.

  • $UNH (UnitedHealth) has been one of the best compounders in the market. Its scale, vertical integration, and cash flow make it a machine that just keeps growing.

  • $JNJ is another giant — diversified across pharma, medical devices, and consumer health. It might not double overnight, but over a decade it quietly builds wealth.

Sometimes the stocks that look boring are the ones you look back on and realize they’ve made you the most money.

The Personalization Gap

Here’s a stat that really jumps out to me:

  • 80% of consumers want personalized healthcare experiences

  • Less than 20% of providers deliver them effectively

That gap is a goldmine. Whoever closes it will create enormous value — and the companies positioned with data, AI, and consumer-first models have the inside track.

Why I’m So Bullish

Tech will continue to matter, no doubt. But healthcare has something tech doesn’t: guaranteed, growing demand.

Combine that with inefficiency, innovation, and massive TAM, and you get one of the most attractive setups for long-term investors.

That’s why I see healthcare as one of the best compounding stories of the next decade.

My focus is a mix of disruptors like $HIMS and $OSCR, paired with compounders like $UNH and $JNJ. That way, I capture both innovation and steady growth.

Bottom Line

The market is crowded when everyone is chasing AI and semis. Healthcare doesn’t get the same hype, but it has all the fundamentals to quietly outperform for patient investors.

Ignore this sector, and you might miss one of the biggest wealth-building opportunities of the next decade.

👉 If you want to see exactly how I’m positioning in healthcare — and get real-time updates on my broader portfolio — I share all of my strategies on Surmount.

Reply

or to participate.